• Comment: Still no significant coverage about Carbone. Adding more works by him is irrelevant - they are essentially primary sources. Notability demands significant coverage about him in reliable, independent, secondary sources (please read the relevant guidelines). This draft will continue to be rejected unless/until better sources are provided. Paul W (talk) 12:25, 15 April 2024 (UTC)

• Comment: See the comment left on March 28, we need significant coverage in secondary sources. Qcne (talk) 16:58, 5 April 2024 (UTC)

• Comment: Lots of inline citations of works by Carbone, but almost no citations of significant coverage about Carbone in reliable, secondary, independent sources. Some of the references given do not even mention him, but relate to other figures (Bill Travis) or organisations (People to People). Paul W (talk) 13:34, 28 March 2024 (UTC)

Roberto Giovanni Carbone (born 6 September 1954) is an Italian scientist and clinician, studying the mechanisms and treatment of pulmonary fibrosis, pulmonary hypertension and lung transplantation.

Early life and education

Born in Genoa, Carbone graduated from the University of Genoa^[1] in Medicine and Surgery in 1983 and registered with General Medical Council in 2003.^[2] He obtained a master's degrees in pulmonary hypertension from the University of Michigan and a further master's in respiratory medicine and bronchology from the National Heart and Lung Institute Royal Brompton Hospital Imperial & College in London^[3], in asthma at the University of Denver, in Pneumology at University of Montpellier and in asthma and COPD from the University of Ferrara.

After specializing in pulmonary diseases and respiratory pathophysiology, he undertook clinical training at the regional Hospital of Aosta as deputy head physician.^[4][5]

From 2020 to 2022 he worked as clinical researcher at University of Genoa.^[6]

In 2023 he became a fellow of the Royal Society of Medicine, London.^[7][8]

He was awarded an honorary professorship in 2022 and is a senior consultant cardio-respiratory physician at University of Genoa.^[9]

Research

His research initially focused on the study of alpha-1 antitrypsin deficiency pulmonary emphysema, and urinary degradation products (desmosin) and prolastin treatment working in the lab of Gordon L. Snider (Harvard University). He dedicated himself to the study of lung cancer, creating the first Italian Cancer Registry with the patronage of the Istituto Superiore di Sanità in the figure of Marco Geddes di Filicaja, at IST (Scientific Institute of Tumors) in Genoa under the direction of Leonardo Santi.

He studied the pathologies of asbestos, such as pleural mesothelioma at Scansetti Interdepartmental Center in Turin where he collaborated with Roberto Compagnoni of University of Turin and Bice Fubini also enrolled in the Academy of Sciences of Turin. Subsequently he studied the role of neuropeptides (neurotensin)^[10] in asthma adrenergic regulation with Giovanni Bottino (University of Genoa).^[11] He went on to win the first prize as speaker and author in Italian CHEST congress (American College of Chest Physicians).^[12] The study entitled In vivo the micro-environmental reactivity in asthmatic^[13] took place over a period of 15 years and was the first in the world to evaluate bronchial hyperreactivity in asthmatic subjects in vivo and in vitro and to do research on the use of new radioactive isotopes as indium-111 and octreotide (labeled somatostatin) in interstitial lung diseases and sarcoidosis.^[14]

His first book entitled Pulmonary Arterial Hypertension and Interstitial Lung Diseases published in 2009 is held in Capitol Hill Library^[15](Washington D.C.), at MIT in Boston, at the National Institute of Health, at Moscow University and is also in widespread readership in China.^[16] This book is a seminal text which introduced conjoined treatment of pulmonary hypertension and pulmonary fibrosis since the International Congress "World Association Sarcoidosis and Other Granulomatous Disorders' ' (WASOG) in Denver in 2005.^[17] His third book entitled Lung Transplantation - Evolving Knowledge and New Horizons, a collaboration with Mario Viganò contains a first chapter entitled "The History of Lung Transplantation"^[18] which is considered by the Book Authority one of the best books on thoracic surgery of all time. In 2023 this is positioned fifty-second in the "Best Thoracic Surgery eBooks of all time" ranking.^[19]

In 2007, William (Bill) D. Travis, directed Carbone to the study of pneumonia of the pulmonary interstitium in the lung deep area which was not attributable to inflammation bacteria or viruses, rather of unknown cause. Carbone discovered through the study of Indium^[20] and pulmonary hypertension that fibrotic pneumonia has a high mortality rate.^[21]

Publications

Carbone is the author of over 150 publications in peer-reviewed journals.^[22]

He was a member of the editorial board of the scientific journal CHEST^[23] and is an associate editor of the journal Frontiers. He has published 5 books in English as a scientific editor.^[24] Scopus reported approximately 1000 citations.^[25][26]

Honors and awards

• 1994: First prize, as speaker and author, 8th World Congress of Bronchology in Munich. Title of the study: "The open window thoracoscopy procedure for bronchopleural fistula with persistent empyema following pneumonectomy".
• 1997: Fellow of the American College of CHEST Physicians (FCCP)^[27][28][29]
• 2000: First prize, as speaker and author together with Professor Giovanni Bottino at National Congress of CHEST (American College of Chest Physicians). Title of the study: "In vivo microenvironmental reactivity in asthma"
• 2003: Letter of Commendation from Editor-in-Chief of CHEST Journal (IF 10), Prof. A Jay Block MD, Master FCCP, Professor Emeritus of Medicine, University of Florida.^[30]
• 2004 - 2019: Served in a number of leadership roles at the American College of Chest Physicians^[31]
• 2006: Member of American delegation National Institute of Health (NIH) in association with “People to People Ambassador Program” (Head of Delegation Prof. Denis Mc Cool, Brown University), with the support of Prof. Claude Lenfant (Director of NIH) for scientific exchanges between United States and CHINA – President People to People (USA) Dr. Mary Jean Eisenhower.
• 2009: Letter of Commendation from Editor-in-Chief of Annals of Internal Medicine (IF 39.2), Professor Harold C Sox, MD, MACP, USA.^[32]
• 2009: Letter of Commendation from Professor R.P. Baughman (Director of Respiratory Medicine, University of Cincinnati for published book project, title: "Pulmonary Arterial Hypertension and Interstitial Lung Diseases. A Clinical Guide."^[33]
• 2009: Invitation from Editor-in-Chief of Thorax (IF 9.02) to join the journal's editorial board^[34]
• 2010: Citation from Editor-in-Chief of British Medical Journal (IF 105.7) for the article on the topic of risk factors in Cardiology
• 2012: American Thoracic Society Leadership for COPD (National Quality Form USA)^[35][36][37]
• 2017: Personal invitation letter from the President of the American Thoracic Society to participate in the World Meeting which took place in May 2017 in Washington (DC) as an International Member representing Italy^[38]
• 2017: Invitation of the Swiss Confederation of Pneumology to CHEST Meeting in Basel^[39]
• 2023: Fellow of the Royal Society Medicine in London.^[40][41][42]
• 2023: Fellow of the American Heart Association.^[43]
• 2024: Received King Charles III Honor and Proud Letter from Professor Roger Kirby, President Royal Society Medicine.^[44]

References